Cleared Traditional

K162276 - SeraQuest Herpes Type 1 Specific IgG

K162276 is the FDA 510(k) clearance for SeraQuest Herpes Type 1 Specific IgG by Quest International, Inc.. It is a Class 2 Microbiology device (product code MXJ) cleared through the Traditional 510(k) pathway after a 50-day FDA review.

K162276 · Quest International, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2016
Decision
50d
Days
Class 2
Risk

K162276 is an FDA 510(k) clearance for the SeraQuest Herpes Type 1 Specific IgG. Classified as Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1 (product code MXJ), Class II - Special Controls.

Submitted by Quest International, Inc. (Mami, US). The FDA issued a Cleared decision on October 1, 2016 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Quest International, Inc. devices

Submission Details

510(k) Number K162276 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 12, 2016
Decision Date October 01, 2016
Days to Decision 50 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 102d · This submission: 50d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MXJ Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3305
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - MXJ Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1

All 10
Devices cleared under the same product code (MXJ) and FDA review panel - the closest regulatory comparables to K162276.
ARCHITECT HSV-1 IgG, ARCHITECT HSV-1 IgG Calibrator, ARCHITECT HSV-1 IgG Controls
K213987 · Biokit, S.A. · Sep 2023
Elecsys HSV-1 IgG (08948844160)
K220923 · Roche Diagnostics · Oct 2022
ADVIA Centaur Herpes-1 IgG
K181333 · Biokit, S.A. · Aug 2018
ELECSYS HSV-1 IGG IMMUNOASSAY ELECSYS PRECICONTROL HSV
K120625 · Roche Diagnostics · Jul 2012
BIOPLEX 2200 HSV-1 AND HSV-2 IGG KIT
K120959 · Bio-Rad Laboratories · Jun 2012
ZEUS ELISA HSV GC-I IGG TEST SYSTEM
K103363 · Zeus Scientific, Inc. · Apr 2011